Gain-of-Function and Loss-of-Function Mutations in the RyR2-Expressing Gene Are Responsible for the CPVT1-Related Arrhythmogenic Activities in the Heart

Mutations in the ryanodine receptor (RyR2) gene have been linked to arrhythmia and possibly sudden cardiac death (SCD) during acute emotional stress, physical activities, or catecholamine perfusion. The most prevalent disorder is catecholaminergic polymorphic ventricular tachycardia (CPVT1). Four pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Roshan Paudel, Mohsin Saleet Jafri, Aman Ullah
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Current Issues in Molecular Biology
Subjects:
Online Access:https://www.mdpi.com/1467-3045/46/11/767
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846153844278427648
author Roshan Paudel
Mohsin Saleet Jafri
Aman Ullah
author_facet Roshan Paudel
Mohsin Saleet Jafri
Aman Ullah
author_sort Roshan Paudel
collection DOAJ
description Mutations in the ryanodine receptor (RyR2) gene have been linked to arrhythmia and possibly sudden cardiac death (SCD) during acute emotional stress, physical activities, or catecholamine perfusion. The most prevalent disorder is catecholaminergic polymorphic ventricular tachycardia (CPVT1). Four primary mechanisms have been proposed to describe CPVT1 with a RyR2 mutation: (a) gain-of-function, (b) destabilization of binding proteins, (c) store-overload-induced Ca<sup>2+</sup> release (SOICR), and (d) loss of function. The goal of this study was to use computational models to understand these four mechanisms and how they might contribute to arrhythmia. To this end, we have developed a local control stochastic model of a ventricular cardiac myocyte and used it to investigate how the Ca<sup>2+</sup> dynamics in the mutant RyR2 are responsible for the development of an arrhythmogenic episode under the condition of β-adrenergic (β-AR) stimulation or pauses afterward. Into the model, we have incorporated 20,000 distinct cardiac dyads consisting of stochastically gated L-type Ca<sup>2+</sup> channels (LCCs) and ryanodine receptors (RyR2s) and the intervening dyadic cleft to analyze the alterations in Ca<sup>2+</sup> dynamics. Recent experimental findings were incorporated into the model parameters to test these proposed mechanisms and their role in triggering arrhythmias. The model could not find any connection between SOICR and the destabilization of binding proteins as the arrhythmic mechanisms in the mutant myocyte. On the other hand, the model was able to observe loss-of-function and gain-of-function mutations resulting in EADs (Early Afterdepolarizations) and variations in action potential amplitudes and durations as the precursors to generate arrhythmia, respectively. These computational studies demonstrate how GOF and LOF mutations can lead to arrhythmia and cast doubt on the feasibility of SOICR as a mechanism of arrhythmia.
format Article
id doaj-art-0ed7a3531f41424a83dd8f259c23d152
institution Kabale University
issn 1467-3037
1467-3045
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Current Issues in Molecular Biology
spelling doaj-art-0ed7a3531f41424a83dd8f259c23d1522024-11-26T17:58:03ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452024-11-014611128861291010.3390/cimb46110767Gain-of-Function and Loss-of-Function Mutations in the RyR2-Expressing Gene Are Responsible for the CPVT1-Related Arrhythmogenic Activities in the HeartRoshan Paudel0Mohsin Saleet Jafri1Aman Ullah2School of Systems Biology, George Mason University, Fairfax, VA 22030, USASchool of Systems Biology, George Mason University, Fairfax, VA 22030, USASchool of Systems Biology, George Mason University, Fairfax, VA 22030, USAMutations in the ryanodine receptor (RyR2) gene have been linked to arrhythmia and possibly sudden cardiac death (SCD) during acute emotional stress, physical activities, or catecholamine perfusion. The most prevalent disorder is catecholaminergic polymorphic ventricular tachycardia (CPVT1). Four primary mechanisms have been proposed to describe CPVT1 with a RyR2 mutation: (a) gain-of-function, (b) destabilization of binding proteins, (c) store-overload-induced Ca<sup>2+</sup> release (SOICR), and (d) loss of function. The goal of this study was to use computational models to understand these four mechanisms and how they might contribute to arrhythmia. To this end, we have developed a local control stochastic model of a ventricular cardiac myocyte and used it to investigate how the Ca<sup>2+</sup> dynamics in the mutant RyR2 are responsible for the development of an arrhythmogenic episode under the condition of β-adrenergic (β-AR) stimulation or pauses afterward. Into the model, we have incorporated 20,000 distinct cardiac dyads consisting of stochastically gated L-type Ca<sup>2+</sup> channels (LCCs) and ryanodine receptors (RyR2s) and the intervening dyadic cleft to analyze the alterations in Ca<sup>2+</sup> dynamics. Recent experimental findings were incorporated into the model parameters to test these proposed mechanisms and their role in triggering arrhythmias. The model could not find any connection between SOICR and the destabilization of binding proteins as the arrhythmic mechanisms in the mutant myocyte. On the other hand, the model was able to observe loss-of-function and gain-of-function mutations resulting in EADs (Early Afterdepolarizations) and variations in action potential amplitudes and durations as the precursors to generate arrhythmia, respectively. These computational studies demonstrate how GOF and LOF mutations can lead to arrhythmia and cast doubt on the feasibility of SOICR as a mechanism of arrhythmia.https://www.mdpi.com/1467-3045/46/11/767CPVT1RyR2gain-of-functionβ-adrenergicloss-of-functionEAD
spellingShingle Roshan Paudel
Mohsin Saleet Jafri
Aman Ullah
Gain-of-Function and Loss-of-Function Mutations in the RyR2-Expressing Gene Are Responsible for the CPVT1-Related Arrhythmogenic Activities in the Heart
Current Issues in Molecular Biology
CPVT1
RyR2
gain-of-function
β-adrenergic
loss-of-function
EAD
title Gain-of-Function and Loss-of-Function Mutations in the RyR2-Expressing Gene Are Responsible for the CPVT1-Related Arrhythmogenic Activities in the Heart
title_full Gain-of-Function and Loss-of-Function Mutations in the RyR2-Expressing Gene Are Responsible for the CPVT1-Related Arrhythmogenic Activities in the Heart
title_fullStr Gain-of-Function and Loss-of-Function Mutations in the RyR2-Expressing Gene Are Responsible for the CPVT1-Related Arrhythmogenic Activities in the Heart
title_full_unstemmed Gain-of-Function and Loss-of-Function Mutations in the RyR2-Expressing Gene Are Responsible for the CPVT1-Related Arrhythmogenic Activities in the Heart
title_short Gain-of-Function and Loss-of-Function Mutations in the RyR2-Expressing Gene Are Responsible for the CPVT1-Related Arrhythmogenic Activities in the Heart
title_sort gain of function and loss of function mutations in the ryr2 expressing gene are responsible for the cpvt1 related arrhythmogenic activities in the heart
topic CPVT1
RyR2
gain-of-function
β-adrenergic
loss-of-function
EAD
url https://www.mdpi.com/1467-3045/46/11/767
work_keys_str_mv AT roshanpaudel gainoffunctionandlossoffunctionmutationsintheryr2expressinggeneareresponsibleforthecpvt1relatedarrhythmogenicactivitiesintheheart
AT mohsinsaleetjafri gainoffunctionandlossoffunctionmutationsintheryr2expressinggeneareresponsibleforthecpvt1relatedarrhythmogenicactivitiesintheheart
AT amanullah gainoffunctionandlossoffunctionmutationsintheryr2expressinggeneareresponsibleforthecpvt1relatedarrhythmogenicactivitiesintheheart